Inhibrx Biosciences, Inc. ($INBX)
Filing Information
| Accession Number | 0001366074-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 14, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
10,040
Total Value
$848,976.84
P&L
+4.9% (+$41,269.96)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 14, 2026 | Purchase | 2,470 | $84.07 | $207,654.63 | 743,018 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Oct 14, 2026 | Purchase | 2,470 | $85.00 | $209,948.02 | 745,488 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Oct 14, 2026 | Purchase | 100 | $85.76 | $8,576.00 | 745,588 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Oct 14, 2026 | Purchase | 2,449 | $84.07 | $205,889.14 | 167,449 | Indirect | By Lappe Descendants' Trust | View Details | |
Director | Common Stock | โ | Oct 14, 2026 | Purchase | 2,451 | $85.00 | $208,333.04 | 169,900 | Indirect | By Lappe Descendants' Trust | View Details | |
Director | Common Stock | โ | Oct 14, 2026 | Purchase | 100 | $85.76 | $8,576.00 | 170,000 | Indirect | By Lappe Descendants' Trust | View Details |